We've released the new Subject Search, designed to be simpler and faster than the application below.
|Student Contribution Band:||Band 2|
|Administered by:||College of Medicine & Dentistry|
Endocrine, genetic disorders and cancerous conditions can cause significant patient distress and may lead to fatal outcomes. Endocrine disorders such as thyroid, adrenal gland dysfunction and reproductive health can require medium to long-term treatment and regular advice by health professionals including pharmacists. Conversely, cancer often requires shorter-term aggressive treatment using an array of medications according to continually changing treatment guidelines. Palliative care involves not only the treatment and care of cancer patients, but of multiple medical conditions that are no longer curable. Pharmacist involvement in palliative care requires a holistic approach in both hospital and community pharmacy. Pharmacists are a key part of multidisciplinary teams for many of the aforementioned conditions, and students will learn how to manage these conditions effectively, including being able to tailor therapy relevant to individual patient needs. Students will also develop skills in the conduct of medication management in complex clinical case scenarios.
|As this is a core level 4 subject in the BPharm(Hons)/MPharm pathway, students will be expected to have completed all core level 1, 2 and 3 subjects.|
|Townsville, Study Period 1, Internal|
|Census Date 23-Mar-2023|
|Coordinator:||Mrs Amanda Mackay|
|Lecturers:||Mrs Joanne Roache, Mrs Gillian Knott, Professor Beverley Glass, Dr Martina Mylrea, Assoc. Professor John Smithson, Mr Shane MacDonald, Ms Michelle Rothwell, Dr Robi Islam, Mrs Monika Leka.|
The student workload for this 6 credit point subject is approximately 260 hours.
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.